The Claim
Pharmacologically induced hypogonadism in healthy young men attenuates resistance training-induced activation of key anabolic signaling proteins AKT (Ser473) and mTORC1 (Ser2448), with placebo recipients exhibiting 5.5-fold and 3.6-fold increases respectively after training, while hypogonadal men show only 2.74-fold and 1.9-fold increases, indicating that testosterone enables full mechanotransduction signaling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When young men have low testosterone on purpose for the study, their muscles don’t respond as well to weight training at the cellular level — testosterone seems to help muscles fully 'feel' and react to the workout.
See the scientific wording
Pharmacologically induced hypogonadism in healthy young men attenuates resistance training-induced activation of key anabolic signaling proteins, including AKT (Ser473) and mTORC1 (Ser2448), with placebo recipients showing 5.5-fold and 3.6-fold increases respectively after training, while hypogonadal men show only 2.74-fold and 1.9-fold increases, indicating testosterone enables full mechanotransduction signaling.
What the research says
1 studyThe study shows that when young men have low testosterone, their muscles don’t respond as well to weight training at the molecular level, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.